CLINICAL_TRIALS
trial_result
· 2020-07-15
Clinical Trial Update: Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating implantation of mesenchymal stem cell, conditioned medium, or triamcinolone acetonide for keloids.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Keloid | Phase 1, Phase 2 | Status: UNKNOWN